Search box

Resources

Explore a range of resources related to our PAXgene tubes, kits and devices, including handbooks (instructions for use), brochures, technical notes and posters. View or download these documents to find out more about the full line of PAXgene products.



293 KB
QIAsymphony® SP Instrument Instructions for Use (Protocol Sheet) (FR)
768566
Handbooks
655 KB
QIAsymphony® SP Instrument Instructions for Use (Protocol Sheet) (EN)
768566
Handbooks
90 KB
(FR) Important Note: PreAnalytiX GmbH street address has changed from “Feldbachstrasse” to “Garstligweg 8”
762164, 762174, 768566
Technical Notes
647 KB
How to Collect Blood Using the PAXgene Blood RNA Tube for Molecular Testing
762165
Brochures
7 MB
Digital PCR-based EGFR T790M Mutation Detection From Human Blood Samples Collected in PAXgene® Blood ccfDNA Tubes (Neander, AACR 2023)
768115, 768165
Posters
Takamatsu, R. et al. (2023) Clinical predominance of whole‐exome sequencing to evaluate microsatellite instability status. Cancer Science. 2023;00:1–12
765312
References
PAXgene Blood DNA Tube (IVD) Handbook
761165
Handbooks
3 MB
How to Collect Blood Using the PAXgene® Blood ccfDNA Tube (CE-IVD) For Circulating Cell-Free DNA (ccfDNA) and Genomic DNA (gDNA)
768165
Brochures
956 KB
Purification of DNA from the PAXgene® Saliva Collectors using the Gentra® Puregene® Cell Kit
769040
Supplementary Protocols
R, Li. et al. (2022) Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancer. Cancer Cell. 2022-Elsevier
765312, 765512
References
Karras, P. et al. (2022) A cellular hierarchy in melanoma uncouples growth and metastasis, Nature 2022
765312, 765512
References
PAXgene Blood ccfDNA Tube (CE-IVD)
768165
FAQs
Radani, N. et al. (2022) Analysis of Fecal, Salivary, and Tissue Microbiome in Barrett's Esophagus, Dysplasia, and Esophageal Adenocarcinoma. Gastro Hep Advances 2022;1:755–766
765312, 765512
References
1 MB
QIAsymphony Protocol Sheet PAXgene ccfDNA_2400 and ccfDNA_4800
768566
Supplementary Protocols
Marsden, T. et al. (2022) The ReIMAGINE prostate cancer risk study protocol: A prospective cohort study in men with a suspicion of prostate cancer who are referred onto an MRI-based diagnostic pathway with donation of tissue, blood and urine for biomarker analyses. PLoS One. 2022; 17(2): e0259672.
765312, 765512
References

Please note

You will now be redirected to BD.com. On the next page, select ‘Healthcare professional’, then select your country from the menu. Finally, enter the catalog number () to access and download the Instructions for Use.